- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Frameworks for Advancing Health Equity: Accessing Ketamine-Assisted Therapy
Jessica Tracy, head of Growth and Partnerships at Enthea, shares how employers and unions can support mental health and address access barriers to evidence-based ketamine treatments.
The Center on Health Equity & Access relaunches its Frameworks for Advancing Health Equity podcast series in 2025 with a focus on improving mental health in the workforce.
Last month, The Greater Philadelphia Business Coalition on Health hosted its Mental Health Summit, which featured discussions on how employers can understand the mental health needs of the workforce, build a culture around health, and explore innovative treatment approaches. This episode offers a deep dive into psychedelic-assisted therapy with Jessica Tracy, who spoke at the event. Her presentation, Revolutionizing Mental Health with Psychedelic-Assisted Therapy, set the stage for employers and unions that want to support the mental health of their employees and address access barriers to evidence-based ketamine treatments.
Tracy serves as the head of Growth and Partnerships at Enthea, a company dedicated to improving mental health by providing innovative psychedelic-assisted treatment services that can be integrated into existing benefits plans, therefore facilitating greater access to these therapies.
Previous episodes of Frameworks for Advancing Health Equity:
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More
